Chandra, S., & Pahan, K. (2019). Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease via Peroxisome Proliferator-Activated Receptor α. J Alzheimers Dis Rep.
Chicago-tyylinen lähdeviittausChandra, Sujyoti, ja Kalipada Pahan. "Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease Via Peroxisome Proliferator-Activated Receptor α." J Alzheimers Dis Rep 2019.
MLA-viiteChandra, Sujyoti, ja Kalipada Pahan. "Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease Via Peroxisome Proliferator-Activated Receptor α." J Alzheimers Dis Rep 2019.